A Randomised Phase II Study of Pegylated Liposomal Doxorubicine in Elderly Patients with Acute Lymphoblastic Leukemia (ALL): The GRAALL-SA1 Study

被引：0

作者：

Hunault-Berger, Mathilde

Leguay, Thibaut ^{[1
]}

Thomas, Xavier ^{[2
]}

Legrand, Ollivier ^{[3
]}

Huguet, Francoise ^{[4
]}

Witz, Francis ^{[5
]}

Escoffre-Barbe, Martine ^{[6
]}

Legros, Laurence ^{[7
]}

Turlure, Pascal ^{[8
]}

Chevallier, Patrice ^{[9
]}

Larosa, Fabrice ^{[10
]}

Cahn, Jean-Yves

Reman, Oumedaly ^{[11
]}

Rousselot, Philippe ^{[12
,13
]}

Delannoy, Andre ^{[14
]}

Dhedin, Nathalie ^{[15
]}

Pochitaloff, Marina ^{[16
]}

Bene, Marie-Christine

Ifrah, Norbert ^{[17
]}

Dombret, Herve ^{[18
]}

机构：

[1] CH Bordeaux, Bordeaux, France

[2] GRAAL Grp, Lyon, France

[3] Hop Hotel Dieu, F-75181 Paris, France

[4] CHU Toulouse, Toulouse, France

[5] Hop Brabois, Nancy, France

[6] Hop Pontchaillou, Hematol Clin, Rennes, France

[7] CHU Nice, Nice, France

[8] CHU Limoges, Limoges, France

[9] CHU Hotel Dieu, Nantes, France

[10] CHU Jean Minjoz, INSERM, UMR645, Besancon, France

[11] CHU Caen, F-14000 Caen, France

[12] Hop Mignot, Versailles, France

[13] CIC9504, Versailles, France

[14] Hop Jolimont, Haine St Paul, Belgium

[15] Hop La Pitie Salpetriere, Serv Hematol Clin, Paris, France

[16] Cytogenet, Marseille, France

[17] CHU Angers, Serv Malad Sang, Angers, France

[18] Hop St Louis, AP HP, Paris, France

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：340 / 340

页数：1

共 50 条

[21] Outcome of Younger Adults with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse: A Graall Study
Desjonqueres, Alexandre
Chevallier, Patrice
Thomas, Xavier
Huguet, Francoise
Leguay, Thibault
Bernard, Marc
Bay, Jacques-Olivier
Tavernier, Emmanuelle
Charbonnier, Aude
Isnard, Franoise
Hunault, Mathilde
Turlure, Pascal
Renaud, Marc
Bastie, Jean-Noel M.
Himberlin, Chantal
Lepretre, Stephane
Lioure, Bruno
Lheritier, Veronique
Asnafi, Vahid
Beldjord, Kheira
Lafage, Marina
Ifrah, Norbert
Dombret, Herve
BLOOD, 2014, 124 (21)
[22] Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia
Sasaki, Koji
Kantarjian, Hagop
Wierda, William
Ravandi-Kashani, Farhad
Jorgensen, Jeffrey
Wang, Sa A.
Khoury, Joseph
Daver, Naval
Burger, Jan
Di Nardo, Courtney D.
Jain, Nitin
Short, Nicholas J.
Estrov, Zeev
Konopleva, Marina
Ohanian, Maro
Garcia-Manero, Guillermo
Kadia, Tapan
Alvarado-Valero, Yesid
Yilmaz, Musa
Pierce, Sherry
Garris, Rebecca
Ingram, April
Cortes, Jorge
O'Brian, Susan
Jabbour, Elias
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 734 - 739
[23] Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients
Miller, Kevin C.
Al-Kali, Aref
Shah, Mithun V.
Hogan, William J.
Elliott, Michelle A.
Begna, Kebede H.
Gangat, Naseema
Patnaik, Mrinal M.
Viswanatha, David S.
He, Rong
Greipp, Patricia T.
Sproat, Lisa Z.
Foran, James M.
Litzow, Mark R.
Alkhateeb, Hassan B.
LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 990 - 999
[24] Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
von Stackelberg, Arend
Locatelli, Franco
Zugmaier, Gerhard
Handgretinger, Rupert
Trippett, Tanya M.
Rizzari, Carmelo
Bader, Peter
O'Brien, Maureen M.
Brethon, Benoit
Bhojwani, Deepa
Schlegel, Paul Gerhardt
Borkhardt, Arndt
Rheingold, Susan R.
Cooper, Todd Michael
Zwaan, Christian M.
Barnette, Phillip
Messina, Chiara
Michel, Gerard
DuBois, Steven G.
Hu, Kuolung
Zhu, Min
Whitlock, James A.
Gore, Lia
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4381 - +
[25] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
Ruey-Long Hong
Yun-Long Tseng
Cancer Chemotherapy and Pharmacology, 2003, 51 : 433 - 438
[26] A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
Hong, RL
Tseng, YL
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (05) : 433 - 438
[27] Design Of a Phase 1/2 Study Of Moxetumomab Pasudotox In Adult Patients With Relapsed and/Or Refractory Acute Lymphoblastic Leukemia (ALL)
Ravandi, Farhad
Kantarjian, Hagop M.
Goswami, Trishna
Wang, Fujun
Ibrahim, Ramy
BLOOD, 2013, 122 (21)
[28] Phase 1 study of pegylated liposomal doxorubin and gemcitabine in patients with advanced malignancies
Fracasso, PM
Blum, KA
Tan, BR
Fears, CL
Bartlett, NL
Arquette, MA
Clark, RS
CANCER, 2002, 95 (10) : 2223 - 2229
[29] Phase I/II study of clofarabine plus cyclophosphamide in adults with relapsed and refractory acute lymphoblastic leukemia (ALL)
Faderl, Stefan
Thomas, Deborah A.
Gandhi, Varsha
Borthakur, Gautam
Huang, Xuelin
Plunkett, William
Burger, Jan
Cortes, Jorge
O'Brien, Susan
Ravandi, Farhad
Bretz, Jennie
Kwari, Monica
Kantarjian, Hagop M.
BLOOD, 2007, 110 (11) : 152B - 152B
[30] Intensified Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): A Phase II Study from the Dana Farber Cancer Institute (DFCI) ALL Consortium
Fathi, Amir T.
DeAngelo, Daniel J.
Stevenson, Kristen E.
Kolitz, Jonathan E.
Asch, Julie D.
Amrein, Philip C.
Attar, Eyal C.
Steensma, David P.
Wadleigh, Martha
Connolly, Christine
Galinsky, Ilene
Stone, Richard M.
Neuberg, Donna S.
Ballen, Karen K.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →